MetaVia is trading at $1.35, up 9.76% before the market opens on October 20, based on the supplied price context.
- That is up from the October 19 close of $1.23.
- No new company-specific announcement explaining the move was found. The latest company news located was the October 13 appointment of Sarah Browne as chief medical officer; that earlier announcement does not establish a cause for the pre-market rise.
- Prior after-hours coverage also reported a rise without identifying a clear catalyst.